Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-07

Clinical Trial Update: Comparison of Dexmedetomidine and Propofol-Remifentanil Conscious Sedation for Awake Craniotomy for Tumor Surgery [NA]

View source ↗

Summary

This completed clinical trial compares dexmedetomidine with propofol-remifentanil for conscious sedation during awake craniotomy in brain tumor patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PROPOFOL (Propofol)
  • Remifentanil (remifentanil)

Snippet

Sponsor: Nicolai Goettel | Conditions: Brain Tumor | NA | Status: COMPLETED